dr. reardon on nivolumab/ipilimumab in glioblastoma
Published 8 years ago • 762 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
2:03
dr. reardon on the immunogenicity of glioblastoma
-
1:34
dr. reardon on pembrolizumab and bevacizumab for glioblastoma
-
2:09
dr. reardon on efficacy/safety of immunotherapy combination in glioblastoma
-
1:06
dr. sampson on nivolumab monotherapy for recurrent glioblastoma
-
1:54
david reardon on caring for patients with glioblastoma
-
3:32
ipilimumab and nivolumab for newly diagnosed glioblastoma (gbm)
-
1:20
dr. reardon on the need for a new standard of care in gbm
-
2:15
dr. reardon on a phase 1/2 trial examining ino-5401 and ino-9012 in glioblastoma
-
0:39
dr. atkinson on when to use nivolumab monotherapy versus nivolumab/ipilimumab combination
-
2:31
dr. reardon on a personalized neoantigen-targeting vaccine for gbm
-
5:39
nivolumab plus ipilimumab in advanced melanoma
-
1:34
dr. sharpless on managing toxicities with nivolumab/ipilimumab in melanoma
-
1:34
fda approval of frontline nivolumab/ipilimumab combo in rcc
-
2:03
dr. david reardon on immunotherapy and rindopepimut in the glioblastoma treatment paradigm
-
1:15
dr. postow on nivolumab combined with ipilimumab in melanoma
-
1:05
dr. reardon on updated data from the phase ii react trial
-
1:47
dr. harrison on the possibility of nivolumab plus ipilimumab becoming the new il-2
-
1:43
dr. david reardon on treating glioblastoma patients with egfrviii-mutations
-
1:38
dr. schadendorf on nivolumab/ ipilimumab combination trial in melanoma